MASSANO, DAVIDE

MASSANO, DAVIDE  

SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.109 secondi).
Titolo Data di pubblicazione Autore(i) File
Clinical relevance of deferasirox trough levels in β-thalassemia patients 2018 Allegra, Sarah; Massano, Davide; De Francia, Silvia; Longo, Filomena; Piccione, Francesca; Pirro, Elisa; Cusato, Jessica; D'Avolio, Antonio; Piga, Antonio
Deferasirox AUC efficacy cutoff and role of pharmacogenetics 2016 Allegra, S; Cusato, J; De Francia, S; Massano, D; Piga, A; D'Avolio, A
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 2017 Allegra, Sarah; De Francia, Silvia; Cusato, Jessica; Arduino, Arianna; Massano, Davide; Longo, Filomena; Piga, Antonio; D'Avolio, Antonio
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 2016 Allegra, Sarah; De Francia, Silvia; Cusato, Jessica; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 2017 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 2016 Allegra, Sarah; De Francia, Silvia; Longo, Filomena; Massano, Davide; Cusato, Jessica; Arduino, Arianna; Pirro, Elisa; Piga, Antonio; D'Avolio, Antonio
Deferiprone 2010 A. Piga; S. Roggero; I. Salussolia; D. Massano; M. Serra; F. Longo
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 2018 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 2019 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness 2014 Cusato, J; Allegra, S; Massano, D; De Francia, S; Piga, A; D'Avolio, A.
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 2012 De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A.
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 2018 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 2018 Allegra, Sarah; Cusato, Jessica; DE FRANCIA, Silvia; Arduino, A; Longo, Filomena; Pirro, Elisa; Massano, Davide; DE NICOLO', Amedeo; Piga, Antonio Giulio; D'Avolio, Antonio
Role of pharmacogenetics on deferasirox AUC and efficacy 2016 Cusato, Jessica; Allegra, Sarah; DE FRANCIA, Silvia; Massano, Davide; Piga, Antonio Giulio; D'Avolio, Antonio